Dr Eliot Forster joined Immunocore as chief executive officer in January 2015. He has almost 25 years of experience in the pharmaceutical and biotechnology industry. Dr Forster previously served as chief executive officer of Creabilis since 2010, and prior to that role was chief executive officer of US biotechnology company, Solace Pharmaceuticals Inc.
His other previous roles include head of EU Development and Operations for the EU and Asia at Pfizer, where he was responsible for drug development activities across multiple geographies and brought several drugs to market, and clinical research manager at GlaxoSmithKline.
Dr Forster is currently chairman of the MedCity project that aims to grow a world-leading life sciences cluster in the south east of England. He holds a PhD in neurophysiology from Liverpool University and an MBA from Henley Management College.